Mercer Global Advisors
NVCR icon

Mercer Global Advisors’s NovoCure NVCR Stock Holding History

Mercer Global Advisors’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.03M Buy
68,295
+23,725
+53% +$359K ﹤0.01% 1718
2026
Q1 		$486K Buy
44,570
+11,910
+36% +$149K ﹤0.01% 2009
2025
Q4 		$422K Buy
32,660
+4,124
+14% +$52.9K ﹤0.01% 1984
2025
Q3 		$369K Buy
28,536
+15,160
+113% +$203K ﹤0.01% 1947
2025
Q2 		$238K Buy
+13,376
New +$233K ﹤0.01% 1992
2022
Q2 		– Sell
-3,267
Closed -$271K – 1890
2022
Q1 		$271K Buy
3,267
+496
+18% +$36.5K ﹤0.01% 1564
2021
Q4 		$208K Sell
2,771
-321
-10% -$32.2K ﹤0.01% 1642
2021
Q3 		$359K Buy
3,092
+239
+8% +$36.1K ﹤0.01% 1340
2021
Q2 		$633K Buy
2,853
+697
+32% +$136K ﹤0.01% 1031
2021
Q1 		$285K Buy
+2,156
New +$341K ﹤0.01% 1331

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Mercer Global Advisors's NVCR Position: Q2 2026 in Review

Mercer Global Advisors increased its NovoCure (NVCR) stake by 53% in Q2 2026, buying an estimated $359K and bringing the position to 68,295 shares worth $1.03M. The position accounts for ﹤0.01% of the portfolio, ranked #1718.

Mercer Global Advisors first reported a position in NVCR in Q1 2021 and has held it in 10 quarters since. 216 funds tracked by Wall St. Rank hold NVCR as of Q2 2026.

  • Mercer Global Advisors held 68,295 shares of NovoCure worth $1.03M as of Q2 2026.
  • Mercer Global Advisors bought 23,725 NovoCure shares in Q2 2026, an estimated $359K.
  • NovoCure made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #1718 holding.
  • Mercer Global Advisors first reported a position in NovoCure in Q1 2021 and has held it in 10 quarters since.
  • 216 funds tracked by Wall St. Rank held NovoCure as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.